Citus

1. Executive Summary (Confidence: Moderate)

CITUS is an emerging high-tech venture in the Swiss longevity ecosystem, founded in 2023 as a spin-off from the prestigious ETH Zurich. The company’s core mission is to provide the world’s most accurate skin health analysis by bridging the gap between non-invasive diagnostics and biological longevity science. CITUS has already demonstrated technical and financial traction, securing CHF 375,000 in convertible loan funding in October 2023 to advance its skin health platform. By offering real-time assessments of biological age through skin biomarkers, the startup empowers both consumers and professional wellness providers to optimize health, beauty, and long-term vitality through data-driven personalization.